Gene · 8352
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid Biopsy in Glioblastoma. | Cancers (Basel) | 2022 | 35884454 | PubTator, text mining | PubMed |
| Examining the Intention of Authorization via Apps: Personality Traits and Expanded Privacy Calculus Perspectives. | Behav Sci (Basel) | 2022 | 35877288 | PubTator, text mining | PubMed |
| A case of CIC-rearranged sarcoma with CIC-LEUTX gene fusion in spinal cord. | Neuropathology | 2022 | 35859319 | PubTator, text mining | PubMed |
Synthesis and crystal structure of bis-[trans-di-aqua-(1,4,8,11-tetra-aza-cyclo-tetra-decane-κ4 N 1,N 4,N 8,N 11)nickel(II)] trans-(1,4,8,11-tetra-aza-cyclo-tetra-decane-κ4 N 1,N 4,N 8,N 11)bis-[4,4',4''-(1,3,5-tri-methyl-benzene-2,4,6-tri-yl)tris-(hydrogen phenyl-phospho-nato-κO)]nickel(II) deca-hydrate. | Acta Crystallogr E Crystallogr Commun | 2022 | 35855365 | PubTator, text mining | PubMed |
| Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 | 35852795 | PubTator, text mining | PubMed |
| Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α1-antitrypsin-derived peptide motif. | Nat Nanotechnol | 2022 | 35851383 | PubTator, text mining | PubMed |
| Social Creativity and Entrepreneurial Intentions of College Students: Mediated by Career Adaptability and Moderated by Parental Entrepreneurial Background. | Front Psychol | 2022 | 35837633 | PubTator, text mining | PubMed |
| The Impact of Public Opinion Pressure on Construction Company Green Innovations: The Mediating Effect of Leaders' Environmental Intention and the Moderating Effect of Environmental Regulation. | Front Psychol | 2022 | 35814162 | PubTator, text mining | PubMed |
| A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase. | Dev Cell | 2022 | 35809563 | PubTator, text mining | PubMed |
| Relating Sustainable Business Development Practices and Information Management in Promoting Digital Green Innovation: Evidence From China. | Front Psychol | 2022 | 35800951 | PubTator, text mining | PubMed |
| Adoption of AI-Enabled Tools in Social Development Organizations in India: An Extension of UTAUT Model. | Front Psychol | 2022 | 35795409 | PubTator, text mining | PubMed |
| Mechanisms of chromatin-based epigenetic inheritance. | Sci China Life Sci | 2022 | 35792957 | PubTator, text mining | PubMed |
| Prior perceived losses and investment objectives after stock market crisis: a moderated-mediation model of risk tolerance and loss aversion. | SN Bus Econ | 2022 | 35789708 | PubTator, text mining | PubMed |
| Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome. | J Physiol | 2022 | 35760527 | PubTator, text mining | PubMed |
| H3K27M Mutation Doesn't Mean Worse Prognosis in Old Patients. | Front Oncol | 2022 | 35756637 | PubTator, text mining | PubMed |
| The Impact Imposed by Brand Elements of Enterprises on the Purchase Intention of Consumers-With Experience Value Taken as the Intermediary Variable. | Front Psychol | 2022 | 35756277 | PubTator, text mining | PubMed |
| Social Disconnectedness and Mental Health Problems During the COVID-19 Pandemic in China: A Moderated Mediation Model. | Int J Public Health | 2022 | 35755954 | PubTator, text mining | PubMed |
| The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers. | Int J Mol Sci | 2022 | 35743228 | PubTator, text mining | PubMed |
| The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel. | Biomedicines | 2022 | 35740334 | PubTator, text mining | PubMed |
| Poly(A) capture full length cDNA sequencing improves the accuracy and detection ability of transcript quantification and alternative splicing events. | Sci Rep | 2022 | 35732903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8352/papers?page=21